Mallinckrodt plc to Provide Business Update, Fiscal Year 2016 Financial Guidance and Historical Financial Information Excluding Contrast Media and Delivery Systems (CMDS)
The investor call and question and answer session will take place on
- By telephone: The telephone dial-in number in the U.S. is (877) 359-9508. For participants outside the U.S., the dial-in number is (224) 357-2393; all callers should use the access code 55504186.
- Through audio replay: A replay of the presentation will be available at
10:30 a.m.U.S. Eastern Time on October 6, 2015, and ending at 11:59 p.m.U.S. Eastern Time on October 20, 2015. The replay dial-in number for U.S. participants is (855) 859-2056. For participants outside the U.S., the replay dial-in number is (404) 537-3406. The replay conference I.D. for the investor call is 55504186. The replay may also be accessed on www.mallinckrodt.com/investors.
- The recast historical financial information will be posted in the Investor Relations section of the company's website.
manufactures, markets and distributes specialty pharmaceutical products and imaging agents. Areas of focus include therapeutic drugs for autoimmune and rare disease specialty areas like neurology, rheumatology, nephrology, and pulmonology; immunotherapy and neonatal respiratory critical care therapies; and analgesics and central nervous system drugs. The company's core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. To learn more about
Senior Vice President, Investor Strategy and IRO
Senior Vice President, Communications and Public Affairs
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mallinckrodt-plc-to-provide-business-update-fiscal-year-2016-financial-guidance-and-historical-financial-information-excluding-contrast-media-and-delivery-systems-cmds-300154386.html